Mads Krogsgaard Thomsen

Last updated

Mads Krogsgaard Thomsen
BornDecember 27, 1960
CitizenshipDanish
EducationDVM, DSc and PhD
EmployerNovo Nordisk Foundation
TitleCEO of Novo Nordisk Foundation
Board member ofTechnical University of Denmark (DTU), University of Copenhagen
HonoursKnight of Order of the Dannebrog

Mads Krogsgaard Thomsen (born December 27, 1960) is a Danish businessman, CEO of the Novo Nordisk Foundation [1] [2] [3] and former Executive Vice President of Research & Development, head of R&D and Chief Scientific Officer (CSO) at the pharmaceutical company Novo Nordisk. [4]

Contents

Education and background

Mads Krogsgaard Thomsen went to boarding school in Epsom, Surrey in Great Britain from 1967 to 1971. He graduated from high school from Rungsted Stateside in 1979. He holds a master's degree from The Royal Veterinary and Agricultural University in 1986, now part of the University of Copenhagen. According to Krogsgaard Thomsen himself, he originally wanted to be a practicing veterinarian, and was inspired by the British television series All Creatures Great And Small. [5] At the Royal Veterinary and Agricultural University, however, he started to take an interest in pursuing a career in either science or the pharmaceutical industry. He finished his PhD. from the same university in 1991.

Career

Mads Krogsgaard Thomsen was employed by Novo Nordisk in 1991 as head of Growth Hormone Research and became Executive Vice President for Diabetes R&D in 1994. He was appointed senior vice president of Diabetes R&D in 1994.

In November 2000, he was appointed executive vice president and Chief Scientific Officer (CSO). [4] From 1994 to 2021 he was responsible for the research and development of 20 medical products specifically within diabetes treatment and the development of GLP-1 and tablet technology used as a replacement for conventional injection-based technology in biological diabetes treatment. He left the position as Senior Vice President of R&D on February 28 in 2021 and took the role as CEO of the Novo Nordisk Foundation on March 1, 2021. [1]

From 2017 to 2019, Thomsen was the chairman of the board of directors at University of Copenhagen. Mads Krogsgaard Thomsen received the royal decoration of Knight of the Order of the Dannebrog by the Danish Royal House on 12 December, 2022. [6]

Personal life

Mads Krogsgaard Thomsen is married to Ulla. Mads has three children from previous marriages. [7]

Related Research Articles

<span class="mw-page-title-main">University of Copenhagen Faculty of Health and Medical Sciences</span>

The Faculty of Health and Medical Sciences at the University of Copenhagen houses 13 departments, 33 centres, five schools, four hospitals, and three libraries.

<span class="mw-page-title-main">Order of the Dannebrog</span> Danish order of chivalry

The Order of the Dannebrog is a Danish order of chivalry instituted in 1671 by Christian V. Until 1808, membership in the Order was limited to fifty members of noble or royal rank, who formed a single class known as White Knights to distinguish them from the Blue Knights who were members of the Order of the Elephant. In 1808, the Order was reformed and divided into four classes. The statute of the Order was amended in 1951 by a Royal Ordinance so that both men and women could be members of the Order. Today, the Order of the Dannebrog is a means of honouring and rewarding the faithful servants of the modern Danish state for meritorious civil or military service, for a particular contribution to the arts, sciences or business life, or for working for Danish interests.

<span class="mw-page-title-main">Novo Nordisk</span> Danish pharmaceutical company

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.

<span class="mw-page-title-main">Hans Christian Hagedorn</span>

Hans Christian Hagedorn was the creator of NPH insulin and the founder of Nordisk Insulinlaboratorium, which is known today as Novo Nordisk.

The Bodil Award for Best Actor in a Leading Role is one of the merit categories presented annually by the Danish Film Critics Association at the Bodil Awards. Created in 1948, it is one of the oldest film awards in Europe, and it honours the best performance by an actor in a leading role in a Danish produced film. The jury can decide not to hand out the award. This has happened five times, in 1952, 1970, 1976, 1985, and in 1986.

The Robert Award for Best Actor in a Leading Role is a Danish Film Academy award presented at the annual Robert Award ceremony to recognize an actor who has delivered an outstanding leading performance in a Danish film.

<span class="mw-page-title-main">Novo Holdings A/S</span> Danish holding company

Novo Holdings A/S is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion. Danish Kroner and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore.

<i>R</i> (film) 2010 film

R is a 2010 Danish prison drama film written and directed by Tobias Lindholm and Michael Noer, and starring Pilou Asbæk. The film was produced by Nordisk Film. The film follows Rune Pedersen, who is serving a prison sentence of two years in Horsens State Prison. Here he is set to do the dirty work of distributing drugs between departments.

Lise Kingo is a Danish businesswoman who currently serves as Independent Board Director at Danone, Sanofi and Covestro. Kingo is also a member of the Advisory Board for Humanitarian and Development Aid at the Novo Nordisk Foundation.

<span class="mw-page-title-main">Novo Nordisk Foundation</span> International foundation for medical treatment and research

The Novo Nordisk Foundation is an international enterprise foundation focusing on medical treatment and research.

<span class="mw-page-title-main">Kåre Schultz</span> Danish business executive (born 1961)

Kåre Schultz is a Danish business executive. Was the chief executive officer of Teva Pharmaceutical Industries between September 2017 - December 2022.

<span class="mw-page-title-main">Frederik Stjernfelt</span> Danish professor

Frederik Stjernfelt is a Danish professor and writer. As a professor, he lectures in science studies, history of ideas, and semiotics, at Aalborg University's Copenhagen department.

Thomas Rørdam is a Danish lawyer and former President of the Supreme Court of Denmark.

<span class="mw-page-title-main">Jesper Møller (mathematician)</span> Danish mathematician (born 1957)

Jesper Møller is a Danish mathematician.

Christian S. Jensen is a Danish computer scientist who is a professor at Aalborg University.

<span class="mw-page-title-main">Lars Rebien Sørensen</span> Danish businessman

Lars Rebien Sørensen is a Danish businessman and former CEO of the pharmaceutical company Novo Nordisk and current chairman of the board at the Novo Nordisk Foundation and Novo Holdings A/S.

<span class="mw-page-title-main">Kristian Pihl Lorentzen</span> Danish politician

Kristian Pihl Lorentzen is a Danish politician and author, who is a member of the Folketing for the Venstre political party. He was elected into parliament at the 2005 Danish general election.

William Bernard McGregor is an Australian linguist and professor in linguistics at Aarhus University. He specializes in the description of mainly non-Pama-Nyungan Australian languages and does descriptive linguistic work on Gooniyandi, Nyulnyul and Warrwa, but also studies the Shua language in Africa. He works on theoretical and typological issues from within a variation of systemic functional linguistics dubbed Semiotic Grammar developed by himself.

<span class="mw-page-title-main">Thomas Sinkjær</span> Danish scientist (born 1958)

Thomas Sinkjær R is a Danish scientist and professor of neuroscience and technology at the Department of Health Science and Technology of Aalborg University, Denmark. He is the Secretary General of the Royal Danish Academy of Sciences and Letters and an elected fellow of the Danish Academy of Technical Sciences.

<span class="mw-page-title-main">Lars Fruergaard Jørgensen</span> Danish businessman (born 1966)

Lars Fruergaard Jørgensen is a Danish businessman, the Chief Executive of Novo Nordisk since January 2017 and Chairman of the European Federation of Pharmaceutical Industries and Associations.

References

  1. 1 2 Mostrup, Christian (February 3, 2021). "Mads Krogsgaard Thomsen appointed as new CEO of the Novo Nordisk Foundation". Novo Nordisk Fonden.
  2. Heimer, Hakon (February 24, 2021). "Leadership Change at Novo Nordisk Foundation | Nordic Society for Precision Medicine". nshg-pm.org. Retrieved May 27, 2021.
  3. "New CEO of the Novo Nordisk Foundation". european-biotechnology.com. February 24, 2021. Retrieved May 27, 2021.
  4. 1 2 "Mads Krogsgaard Thomsen". sciencenews.dk (in Danish). Retrieved May 27, 2021.
  5. Friis, Rasmus (March 3, 2022). "Det hele faldt på plads for Mads Krogsgaard på andet semester". Uniavisen. Retrieved July 6, 2022.
  6. (Danish) - Overview of recipients of Danish decorations: https://www.kongehuset.dk/monarkiet-i-danmark/ordener-og-medaljer/modtagere-af-danske-dekorationer/#oversigt-over-modtagere-af-danske-dekorationer
  7. Mortensen, Thomas Mikkel (October 5, 2019). "Efter ti års fejlslagen forskning fik Mads en dristig idé: Nu har Novo ramt en guldåre". Berlingske.dk (in Danish). Retrieved May 27, 2021.